Add to ORKG<p>Provides information about the beta-blockers: history, mechanism of action, adverse systemic and local effects, the use in the treatment of glaucoma and ocular basic forms used in Russia.</p
The article provides a review of the topical issues of beta-blockers use in the clinical practice. A...
The purpose of the paper is to present the results of the cost-quality evaluation of the SOE group b...
Kenji Inoue Inouye Eye Hospital, Tokyo, Japan Abstract: Glaucoma is a chronic, progressive disease...
PURPOSE. Beta-blockers have been used since the late 1970's as 'first-choice' in the treatment for g...
In the last few years, there has been a marked increase in the number of drugs available for the man...
Background - Several ocular side effects including uveitis, have been reported following topical β b...
In ancient times the term Glaucoma, translated meaning "Sea-Green eye " referred to a grou...
Purpose: To determine whether there were ocular surface changes in glaucomatous patients treated wit...
As life expectancy increases, the incidence of glaucoma is expected to rise worldwide. The review...
Aim. The aim of the study was to evaluate the progression of changes in the visual fields in patient...
PURPOSE: To determine whether there were ocular surface changes in glaucomatous patients treated wit...
Summary. The problem of the reproduced (generic) and original (branded) medications coexistence on t...
The review summarizes the results of modern clinical practice of glaucoma treatment, in which divers...
\ua9 2020 Delta Journal of Ophthalmology | Published by Wolters Kluwer - Medknow. Objective The aim ...
Abstract: Glaucoma is the name given to a group of diseases characterized by incurable, progressive,...
The article provides a review of the topical issues of beta-blockers use in the clinical practice. A...
The purpose of the paper is to present the results of the cost-quality evaluation of the SOE group b...
Kenji Inoue Inouye Eye Hospital, Tokyo, Japan Abstract: Glaucoma is a chronic, progressive disease...
PURPOSE. Beta-blockers have been used since the late 1970's as 'first-choice' in the treatment for g...
In the last few years, there has been a marked increase in the number of drugs available for the man...
Background - Several ocular side effects including uveitis, have been reported following topical β b...
In ancient times the term Glaucoma, translated meaning "Sea-Green eye " referred to a grou...
Purpose: To determine whether there were ocular surface changes in glaucomatous patients treated wit...
As life expectancy increases, the incidence of glaucoma is expected to rise worldwide. The review...
Aim. The aim of the study was to evaluate the progression of changes in the visual fields in patient...
PURPOSE: To determine whether there were ocular surface changes in glaucomatous patients treated wit...
Summary. The problem of the reproduced (generic) and original (branded) medications coexistence on t...
The review summarizes the results of modern clinical practice of glaucoma treatment, in which divers...
\ua9 2020 Delta Journal of Ophthalmology | Published by Wolters Kluwer - Medknow. Objective The aim ...
Abstract: Glaucoma is the name given to a group of diseases characterized by incurable, progressive,...
The article provides a review of the topical issues of beta-blockers use in the clinical practice. A...
The purpose of the paper is to present the results of the cost-quality evaluation of the SOE group b...
Kenji Inoue Inouye Eye Hospital, Tokyo, Japan Abstract: Glaucoma is a chronic, progressive disease...